Dale Stephen
- SEC CIK
- 0001821709
No open-market purchases or sales filed in the past year.
Current role at each company
- KURA Kura Oncology, Inc.Chief Medical Officeras of Jan 31, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Dale Stephen as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2024 (view filing) | Jan 29-30 | 2 days | Dale StephenChief Medical Officer | SSale | −12.0K | $19.31 | −$231.4K | −23.6%38.8K after | 3 lots |
| Jan 31, 2023 (view filing) | Jan 27 | 4 days | Dale StephenChief Medical Officer | SSale | −9.22K | $13.88 | −$128.0K | −25.0%27.7K after | 2 lots |